Please note that a publication can be assigned to several endpoints, i.e. the sum of publications from the individual thematic points and subpoints can be greater than the total sum of actual publications.
Authors | Year | Exposed system | Parameters | Magnetic flux density/field strength |
---|---|---|---|---|
Pang L et al. | 2002 | intact cell/cell culture, K562 cells (human erythroleukemic cell line) | magnetic field, 50/60 Hz | 4.4–13 mT |
Paradisi S et al. | 1993 | intact cell/cell culture, K562 cells (human erythroleukemic cell line) | magnetic field, 50/60 Hz | 2.5 mT |
Parola AH et al. | 2005 | intact cell/cell culture, embryonic chicken fibroblasts, plant, duckweed (<i>Spirodela oligorrhiza</i>) | magnetic field, 50/60 Hz, co-exposure | 0.7 mT |
Pasi F et al. | 2016 | intact cell/cell culture, primary human dermal fibroblasts | magnetic field, 50/60 Hz, therapeutic/medical device | 0.25–1.6 mT |
Paszkiewicz O et al. | 2022 | bacterium, <i>Escherichia coli</i>, <i>Staphylococcus epidermidis</i> | magnetic field, 50/60 Hz, also other exposures without EMF, co-exposure | - |
Patruno A et al. | 2010 | intact cell/cell culture, HaCaT cells (human keratinocytes) | magnetic field, low frequency, 50/60 Hz, electrotherapy | 1 mT |
Patruno A et al. | 2015 | intact cell/cell culture, HaCaT cells (human keratinocytes) | magnetic field, 50/60 Hz, co-exposure | 1 mT |
Pessina GP et al. | 1998 | intact cell/cell culture, peripheral blood mononuclear cells | magnetic field, signals/pulses, 50/60 Hz | 3 mT |
Pessina GP et al. | 2001 | intact cell/cell culture, U-373 MG (human astrocytoma cell line) | magnetic field, signals/pulses, 50/60 Hz, co-exposure | 3 mT |
Phillips JL et al. | 1986 | intact cell/cell culture, human colon carcinoma cell line (Colo 205 and Colo 320 DM) | electric field, magnetic field, 50/60 Hz | 100 µT |
Pica F et al. | 2006 | intact cell/cell culture, BCBL-1 (a latently infected primary effusion lymphoma-derived cell line) | magnetic field, 50/60 Hz | 1 mT |
Potenza L et al. | 2012 | intact cell/cell culture, truffle mycelium <i>Tuber borchii</i> | magnetic field, static magnetic field, 50/60 Hz, DC | 0.1–300 mT |
Pozzi D et al. | 2007 | intact cell/cell culture, LAN-5 cells (human neuroblastoma cell line) | magnetic field, 50/60 Hz | 2 mT |
Qiu L et al. | 2019 | intact cell/cell culture, human amniotic (FL) cells | 50/60 Hz, magnetic field | 0.4 mT |
Rageh MM et al. | 2012 | animal, rat/Wistar, whole body | magnetic field, low frequency, 50/60 Hz | 0.5 mT |
Rahimi S et al. | 2023 | intact cell/cell culture, dental pulp multipotent stromal stem cells | magnetic field, signals/pulses, 50/60 Hz | - |
Ramon C et al. | 1981 | bacterium, <i>Escherichia coli</i>/ATCC 25922 | magnetic field, 50/60 Hz | 2 mT |
Ramstad S et al. | 2000 | bacterium, <i>Propionibacterium acnes</i> | electric field, magnetic field, 50/60 Hz | 200 µT |
Raskmark P et al. | 1996 | intact cell/cell culture, transformed human epithelial amnion cells (AMA) | magnetic field, 50/60 Hz | 20–50 µT |
Razavi S et al. | 2014 | intact cell/cell culture, human adipose derived stem cells | magnetic field, 50/60 Hz | 0.5–1 mT |
Reipert BM et al. | 1996 | intact cell/cell culture, FDCP-mix(A4) cell line (mouse bone marrow cells) | magnetic field, static magnetic field, 50/60 Hz, shielding/field deprivation | 0.2–65 µT |
Restrepo AF et al. | 2016 | intact cell/cell culture, HeLa 229 (human cervical carcinoma cell line), CHO-K1 (Chinese hamster ovary K1 cells) | magnetic field, 50/60 Hz | 0.4–2.53 mT |
Revoltella RP et al. | 1993 | intact cell/cell culture, Friend erythroleukemia cell line (line 3BM-78, clone H19 from line 5-86, line 707M, clone F4-1 from line F4-N) | magnetic field, 50/60 Hz | 200 µT |
Rodriguez de la Fuente AO et al. | 2008 | protozoa, <i>Entamoeba invadens</i> | magnetic field, 50/60 Hz | 1–2 mT |
Rodríguez-de la Fuente AO et al. | 2019 | intact cell/cell culture, <i>Trichomonas vaginalis</i> and <i> Giardia lamblia</i> (protozoans) | magnetic field, 50/60 Hz, co-exposure | 2 mT |
This website uses cookies to provide you the best browsing experience. By continuing to use this website you accept our use of cookies.